首页 | 本学科首页   官方微博 | 高级检索  
     


Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter,prospective real-life study
Authors:Piero Barbanti MD  PhD  Cinzia Aurilia MD  Gabriella Egeo MD  PhD  Luisa Fofi MD  Sabina Cevoli MD  PhD  Bruno Colombo MD  Massimo Filippi MD  Fabio Frediani MD  Francesco Bono MD  Licia Grazzi MD  Antonio Salerno MD  Bruno Mercuri MD  PhD  Antonio Carnevale MD  Claudia Altamura MD  PhD  Fabrizio Vernieri MD
Affiliation:1. Headache and Pain Unit, IRCCS San Raffaele Pisana, Rome, Italy;2. IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy;3. Neurology Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy;4. Headache Center, ASST Santi Paolo Carlo, Milan, Italy;5. Center for Headache and Intracranial Pressure Disorders, Neurology Unit, A.O.U. Mater Domini, Catanzaro, Italy;6. Neuroalgology Unit, Headache Center Fondazione IRCCS Istituto Neurologico “Carlo Besta”, Milan, Italy;7. San Giovanni Addolorata Hospital, Rome, Italy;8. San Filippo Neri Hospital, Rome, Italy;9. Headache and Neurosonology Unit, Policlinico Universitario Campus Bio-Medico, Rome, Italy
Abstract:
Keywords:Calcitonin gene-related peptide  Effectiveness  Erenumab  Real-life  Migraine  Treatment
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号